05/15/2024
4:01 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
4:27 PM | Aligos Therapeutics (Filer)
| Form PRE 14A | |
03/12/2024
3:51 PM | Aligos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
3:15 PM | Aligos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
4:44 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:41 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:42 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/04/2024
4:42 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:28 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
4:29 PM | Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:29 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:30 PM | Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:31 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:32 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:32 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:33 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:34 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:35 PM | Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:23 PM | Aligos Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/08/2024
4:44 PM | Aligos Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
01/30/2024
6:04 AM | Aligos Therapeutics (Subject)
| Form SC TO-I | |
01/25/2024
5:06 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
5:12 AM | Aligos Therapeutics (Subject)
| Form SC TO-C | |
11/28/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 424B3 | |
11/27/2023
11:15 PM | Aligos Therapeutics (Filer)
| Form EFFECT | |
11/17/2023
3:38 PM | Aligos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/15/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:14 PM | Aligos Therapeutics (Issuer)
ROCHE FINANCE LTD (Reporting)
ROCHE HOLDING LTD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2023
4:16 PM | Aligos Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
| Form SC 13G/A | |
11/07/2023
11:03 AM | Aligos Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/06/2023
3:05 PM | Aligos Therapeutics (Subject)
BLATT LAWRENCE (Filed by)
| Form SC 13D | |
11/02/2023
3:23 PM | Aligos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:13 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
3:14 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
3:15 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2023
4:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
7:45 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:05 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:06 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:07 PM | Aligos Therapeutics (Issuer)
Quan Lucinda Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:07 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
09/12/2023
3:08 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:52 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
8:06 PM | Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
6:23 PM | Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:10 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:11 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:13 PM | Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
